Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-10 Purchase |
2022-06-13 4:55 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Collard Craig A Director |
5,700 | $11.1 | $63,266 | 53,822 (Direct) |
View |
| 2022-06-09 Sale |
2022-06-13 4:05 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Sinclair Michael Director 10% Owner |
7,896 | $12.25 | $96,726 | 32,836 (Direct) |
View |
| 2022-06-06 Sale |
2022-06-08 4:39 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Sinclair Michael Director 10% Owner |
8,488 | $12.93 | $109,771 | 40,732 (Direct) |
View |
| 2022-06-02 Sale |
2022-06-06 4:57 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Sinclair Michael Director 10% Owner |
20,000 | $13.73 | $274,623 | 49,220 (Direct) |
View |
| 2022-06-02 Sale |
2022-06-06 4:07 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Gorman Brian General Counsel |
1,148 | $13.52 | $15,521 | 32,438 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-17 4:04 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Silver Gabrielle Alison Director |
2,500 | $13.29 | $33,220 | 21,343 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-17 4:02 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Collard Craig A Director |
27,150 | $13.54 | $367,611 | 48,122 (Direct) |
View |
| 2022-05-13 Purchase |
2022-05-16 4:05 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Collard Craig A Director |
3,689 | $10.49 | $38,698 | 20,972 (Direct) |
View |
| 2022-05-13 Purchase |
2022-05-16 4:03 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | MacDougall Ann L. Director |
3,000 | $10.93 | $32,778 | 26,179 (Direct) |
View |
| 2022-01-27 Sale |
2022-01-27 4:05 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
1,518 | $26.19 | $39,756 | 22,445 (Direct) |
View |
| 2022-01-27 Sale |
2022-01-27 4:03 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
1,995 | $26.15 | $52,169 | 78,488 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:39 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
432 | $30.6 | $13,219 | 35,583 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:37 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
385 | $30.49 | $11,739 | 23,963 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:29 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
1,058 | $30.49 | $32,258 | 80,483 (Direct) |
View |
| 2021-09-21 Sale |
2021-09-23 4:05 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
1,566 | $24.54 | $38,430 | 12,209 (Direct) |
View |
| 2021-09-14 Sale |
2021-09-16 4:14 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
1,571 | $19.37 | $30,431 | 24,109 (Direct) |
View |
| 2021-09-16 Purchase |
2021-09-16 4:12 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
100 | $23.44 | $2,344 | 5,100 (Direct) |
View |
| 2021-09-14 Purchase |
2021-09-15 4:02 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
200 | $19.12 | $3,824 | 24,015 (Direct) |
View |
| 2021-09-13 Purchase |
2021-09-15 4:01 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Collard Craig A Director |
2,500 | $18.13 | $45,325 | 17,283 (Direct) |
View |
| 2021-09-14 Purchase |
2021-09-14 4:01 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Gorman Brian General Counsel |
1,312 | $19.04 | $24,980 | 21,586 (Direct) |
View |
| 2021-09-10 Purchase |
2021-09-13 4:08 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Collard Craig A Director |
9,577 | $18.18 | $174,110 | 13,577 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-09 4:02 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
822 | $18 | $14,796 | 13,512 (Direct) |
View |
| 2021-08-31 Purchase |
2021-09-01 4:04 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer |
2,000 | $17.34 | $34,680 | 17,000 (Direct) |
View |
| 2021-08-23 Sale |
2021-08-25 4:38 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Sinclair Michael Director 10% Owner |
150,000 | $15.71 | $2,356,674 | 279,215 (Direct) |
View |
| 2021-08-19 Sale |
2021-08-20 4:04 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
1,000 | $16.22 | $16,220 | 6,000 (Direct) |
View |
| 2021-08-16 Purchase |
2021-08-16 4:47 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
600 | $15.38 | $9,228 | 23,815 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-14 Option Award |
2022-06-14 4:58 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Daly Richard J Director |
2,000 | $0 | 7,800 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-14 4:55 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Lorianne Masuoka K. Director |
2,000 | $0 | 4,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-14 4:53 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | MacDougall Ann L. Director |
2,000 | $0 | 28,179 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-14 4:51 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Silver Gabrielle Alison Director |
2,000 | $0 | 23,343 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-14 4:49 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
2,000 | $0 | 12,375 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-05 4:22 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Skolnick Phil Chief Scientific Officer |
12,000 | $0 | 24,348 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-05 4:21 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | O'Toole David D Chief Financial Officer |
12,000 | $0 | 36,015 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-05 4:19 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Ellison Mark Jason Heath Chief Development Officer |
12,000 | $0 | 19,636 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-05 4:18 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Gorman Brian General Counsel |
12,000 | $0 | 33,586 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-05 4:16 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer |
12,000 | $0 | 29,000 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-05 4:15 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
40,000 | $0 | 81,541 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-23 4:05 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
3,834 | $10 | 12,209 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-23 4:05 pm |
N/A 2021-11-03 |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
3,834 | $0 | 12,209 (Direct) |
View |
| 2021-09-14 Exercise |
2021-09-16 4:14 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
1,525 | $10 | 24,109 (Direct) |
View |
| 2021-09-14 Exercise |
2021-09-16 4:14 pm |
N/A 2021-11-03 |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
3,025 | $0 | 24,109 (Direct) |
View |
| 2021-09-13 Option Award |
2021-09-15 4:01 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Collard Craig A Director |
700 | $18.07 | 17,283 (Direct) |
View |
| 2021-09-13 Option Award |
2021-09-15 4:01 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Collard Craig A Director |
506 | $17.96 | 17,283 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 4:02 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
1,475 | $10 | 13,512 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 4:02 pm |
N/A 2021-11-03 |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
1,475 | $0 | 13,512 (Direct) |
View |
| 2021-08-23 Exercise |
2021-08-25 4:38 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | Sinclair Michael Director 10% Owner |
150,000 | $5 | 279,215 (Direct) |
View |
| 2021-08-23 Exercise |
2021-08-25 4:38 pm |
2014-06-15 2024-06-14 |
OPIANT PHARMACEUTICALS INC. | OPNT | Sinclair Michael Director 10% Owner |
150,000 | $0 | 279,215 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 4:09 pm |
2022-07-12 2031-07-11 |
OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer |
65,000 | $0 | 65,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-16 4:07 pm |
2022-06-15 2031-06-14 |
OPIANT PHARMACEUTICALS INC. | OPNT | Thomas Thomas T. Director |
4,500 | $0 | 9,500 (Direct) |
View |